<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/trda" ></link>
<id>urn:uuid:c946ffe9-1747-419a-72b3-bef2ee1ae66d</id>
<updated>2026-05-12T22:01:06-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>TRDA: SETHURAMAN NATARAJAN (PR) Sold (AS) 25,907 Shares of ENTRADA THERAPEUTICS INC for $15.39 on 5/4</title>
<link href="http://www.insiderinsights.com/company/trda/entrada-therapeutics-inc/id-6394930" ></link>
<id>urn:uuid:b4f9bfd4-9ca4-1725-7cad-640bd0b9bd24</id>
<updated>2026-05-04T19:25:01-04:00</updated>
<summary type="html" ><![CDATA[ENTRADA THERAPEUTICS INC (TRDA). Recent Price: $6.84. Mkt Cap:265.5mm. 10D Vol: 804,150]]></summary>
</entry>
<entry>
<title>TRDA: DOWDEN NATHAN J (PR,COO) Exercised 15k Options (OE) of ENTRADA THERAPEUTICS INC for $1.74 on 5/4, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/trda/entrada-therapeutics-inc/id-6394929" ></link>
<id>urn:uuid:c3669632-f880-1590-8f93-41ddf31d7d6f</id>
<updated>2026-05-04T19:24:16-04:00</updated>
<summary type="html" ><![CDATA[ENTRADA THERAPEUTICS INC (TRDA). Recent Price: $6.84. Mkt Cap:265.5mm. 10D Vol: 804,150]]></summary>
</entry>
<entry>
<title>TRDA: WENTWORTH KORY JAMES (CFO) Sold (AS) 2,500 Shares of ENTRADA THERAPEUTICS INC for $12.95 on 4/1</title>
<link href="http://www.insiderinsights.com/company/trda/entrada-therapeutics-inc/id-6379246" ></link>
<id>urn:uuid:fe409624-0be4-717c-207e-106839f92fe8</id>
<updated>2026-04-02T16:39:16-04:00</updated>
<summary type="html" ><![CDATA[ENTRADA THERAPEUTICS INC (TRDA). Recent Price: $6.84. Mkt Cap:265.5mm. 10D Vol: 804,150]]></summary>
</entry>
<entry>
<title>TRDA: DOWDEN NATHAN J (PR,COO) Sold (AS) 15,010 Shares of ENTRADA THERAPEUTICS INC for $13.02-$13.05 on 3/9-3/10</title>
<link href="http://www.insiderinsights.com/company/trda/entrada-therapeutics-inc/id-6359111" ></link>
<id>urn:uuid:ec72d473-6305-2087-683f-cefd22930ba2</id>
<updated>2026-03-11T16:35:13-04:00</updated>
<summary type="html" ><![CDATA[ENTRADA THERAPEUTICS INC (TRDA). Recent Price: $6.84. Mkt Cap:265.5mm. 10D Vol: 804,150]]></summary>
</entry>
<entry>
<title>TRDA: WENTWORTH KORY JAMES (CFO) Sold (AS) 16,477 Shares of ENTRADA THERAPEUTICS INC for $13.00-$13.02 on 3/9-3/10</title>
<link href="http://www.insiderinsights.com/company/trda/entrada-therapeutics-inc/id-6359125" ></link>
<id>urn:uuid:8d09cf3b-0610-45b8-eeec-3be004689a2c</id>
<updated>2026-03-11T16:34:08-04:00</updated>
<summary type="html" ><![CDATA[ENTRADA THERAPEUTICS INC (TRDA). Recent Price: $6.84. Mkt Cap:265.5mm. 10D Vol: 804,150]]></summary>
</entry>
<entry>
<title>TRDA: WENTWORTH KORY JAMES (CFO) Sold (AS) 7,988 Shares of ENTRADA THERAPEUTICS INC for $12.25 on 3/4</title>
<link href="http://www.insiderinsights.com/company/trda/entrada-therapeutics-inc/id-6354807" ></link>
<id>urn:uuid:3078964d-dcb8-8c7a-0685-e38f849622fb</id>
<updated>2026-03-06T16:36:45-05:00</updated>
<summary type="html" ><![CDATA[ENTRADA THERAPEUTICS INC (TRDA). Recent Price: $6.84. Mkt Cap:265.5mm. 10D Vol: 804,150]]></summary>
</entry>
<entry>
<title>TRDA: DOSHI DIPAL (CEO,DIR) Disposed (JS) 29,050 Shares of ENTRADA THERAPEUTICS INC for $11.66-$11.76 on 3/2-3/3</title>
<link href="http://www.insiderinsights.com/company/trda/entrada-therapeutics-inc/id-6348840" ></link>
<id>urn:uuid:0cca9439-da93-f69e-4844-3b6e7243b748</id>
<updated>2026-03-03T18:21:25-05:00</updated>
<summary type="html" ><![CDATA[ENTRADA THERAPEUTICS INC (TRDA). Recent Price: $6.84. Mkt Cap:265.5mm. 10D Vol: 804,150]]></summary>
</entry>
<entry>
<title>TRDA: DOSHI DIPAL (CEO,DIR) Acquired (JB) 139,400 Shares of ENTRADA THERAPEUTICS INC for $0.00 on 3/1</title>
<link href="http://www.insiderinsights.com/company/trda/entrada-therapeutics-inc/id-6348839" ></link>
<id>urn:uuid:1078a553-f715-7c9a-efd4-ca5a77adae83</id>
<updated>2026-03-03T18:21:25-05:00</updated>
<summary type="html" ><![CDATA[ENTRADA THERAPEUTICS INC (TRDA). Recent Price: $6.84. Mkt Cap:265.5mm. 10D Vol: 804,150]]></summary>
</entry>
<entry>
<title>TRDA: WENTWORTH KORY JAMES (CFO) Acquired (JB) 44,600 Shares of ENTRADA THERAPEUTICS INC for $0.00 on 3/1</title>
<link href="http://www.insiderinsights.com/company/trda/entrada-therapeutics-inc/id-6348844" ></link>
<id>urn:uuid:690c9bc8-7ba3-0941-ba32-d4aa2eee5784</id>
<updated>2026-03-03T18:20:35-05:00</updated>
<summary type="html" ><![CDATA[ENTRADA THERAPEUTICS INC (TRDA). Recent Price: $6.84. Mkt Cap:265.5mm. 10D Vol: 804,150]]></summary>
</entry>
</feed>